Journal ArticleOPEN ACCESS

Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy

  • Hu Q
  • Kimura Y
  • Ikeda S
  • et al.
BJC Reports (2025) 3(1)
DOI: 10.1038/s44276-025-00158-x
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Circulating tumor DNA (ctDNA) monitoring shows promise for detecting minimal residual disease (MRD) and predicting prognosis in various cancers, but its role in esophageal cancer (EC) post-esophagectomy is unclear. This study evaluated ctDNA for detecting MRD and predicting outcomes in EC patients.

Cite

CITATION STYLE

APA

Hu, Q., Kimura, Y., Ikeda, S., Tanaka, Y., Nakanoko, T., Ota, M., … Oki, E. (2025). Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy. BJC Reports, 3(1). https://doi.org/10.1038/s44276-025-00158-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free